In vivo effects of a selected thiourea derivative 1-(2-chlorobenzoyl)-3-(2,3-dichlorophenyl) against nociception, inflammation and gastric ulcerogenicity: Biochemical, histopathological and in silico approaches.

The current study was designed to investigate the potential of a synthetic therapeutic agent for better management of pain and inflammation, exhibiting minimal to non-existent ulcerogenic effects. The effect of 1-(2-chlorobenzoyl)-3-(2,3-dichlorophenyl) thiourea was assessed through model systems of nociception and anti-inflammatory activities in mice. In addition, the ulcerogenic potential was evaluated in rats using the NSAID-induced pyloric ligation model, followed by histopathological and biochemical analysis. The test was conducted on eight groups of albino rats, comprising of group I (normal saline), groups II and III (aspirin® at doses of 100 mg/kg and 150 mg/kg, respectively), groups IV and V (indomethacin at doses of 100 mg/kg and 150 mg/kg, respectively), and groups VI, VII, and VIII (lead-compound at 15 mg/kg, 30 mg/kg and 45 mg/kg doses, respectively). Furthermore, molecular docking analyses were performed to predict potential molecular target site interactions. The results showed that the lead-compound, administered at doses of 15, 30, and 45 mg/kg, yielded significant reductions in chemically and thermally induced nociceptive pain, aligning with the levels observed for aspirin® and tramadol. The compound also effectively suppressed inflammatory response in the carrageenan-induced paw edema model. As for the ulcerogenic effects, the compound groups displayed no considerable alterations compared to the aspirin® and indomethacin groups, which displayed substantial increases in ulcer scores, total acidity, free acidity, and gastric juice volume, and a decrease in gastric juice pH. In conclusion, these findings suggest that our test compound exhibits potent antinociceptive, anti-inflammatory properties and is devoid of ulcerogenic effects.

Seasonal changes in the scrotal skin histology in relation to thermoregulation and testosterone level in camel and buffalo bull.

This study was conducted to compare the scrotal skin dynamics of camel and buffalo bulls regarding thermoregulation, season and testosterone. Scrotal skin and blood samples (n = 8 each) were collected during breeding (October to March) and non-breeding seasons (April to August). Tissue slides were prepared by the paraffin embedding technique followed by hematoxylin and eosin (H&E) staining and were analysed by ImageJ®. Relative humidity and temperature were recorded in different seasons to calculate the thermal humidity index (THI). Serum testosterone level was estimated through radioimmunoassay (RIA). The data were analysed by applying ANOVA, the THS test was used as a post-ANOVA interface and the correlation coefficient was also calculated among season, testosterone and skin parameters. The results showed that skin thickness, season and THI were negatively correlated with testosterone levels. In the neck, body and apex, the papillary layer was thicker in buffalo bull compared to camel bull during the breeding season; however, the reticular layer followed a reverse trend in the apex when THI was low. In the scrotal neck during the non-breeding season, hair follicle (HF) length and density were recorded high in camel bull compared to buffalo bull when THI was elevated. The density of HF followed the otherwise trend in the apex during the breeding season. The density of SG was found highest in all regions of camel bull as compared to buffalo bull and showed direct relation with THI. To conclude, this study delineates how the histo-dynamics of scrotal skin varies and accommodate itself with testosterone and THI over the different season in camel and buffalo.

Antimicrobial resistance modulation of MDR E. coli by antibiotic coated ZnO nanoparticles.

We evaluated three types of total six preparations against multidrug resistant E. coli i) three antibiotic coated ZnO nanoparticles (gentamicin coated nanoparticle-GNp; chloramphenicol coated nanoparticles-CNp; and both gentamicin & chloramphenicol coated nanoparticle-GCNp), ii) ZnO nanoparticle alone-Np, and iii) two antibiotics used in single (Gentamicin-G; and Chloramphenicol-C). A total of n = 200 sub-clinically positive mastitic milk samples of bovine origin were processed for isolation of MDR E. coli using microbiological and clinical laboratory & standard institute's protocols. ZnO Nps were prepared from zinc acetate dihydrate (Zn (CH3COO)2. 2H2O), polyethylene glycol (C2nH4n+2On+1), and urea (CH4N2O) by standard chemical protocol. Nps were characterized by XRD and STEM analyses while coating of antibiotics on Nps was confirmed by UV-Visible spectrophotometric analysis. Analysis of variance and student t-test were applied at 5% probability using SPSS version 22 statistical software for inferences on obtained data. There was significantly (p < 0.05) lowest minimum inhibitory concentrations (MICs) and highest zone of inhibitions (ZOIs) in case of GCNp (10.42 ± 4.51 µg/mL & 22.00 ± 1.00 mm) followed by GNp (20.79 ± 8.95 µg/mL & 20.00 ± 1.00 mm) and then CNp (25.96 ± 8.95 µg/mL & 12.33 ± 0.57 mm). Percentage increase in ZOI were expressed as 135.8, 78.43, and 312.76% by GCNp when compared with that of G, C, and Np, respectively. GNp and CNp coated preparations exhibited 114.36 and 275.73% increase in ZOI than to that of G and C, respectively. Similar trend was found in percentage reduction of MICs of preparations. Highest filamentation, indicator of bacterial damage, of E. coli was noted at MIC of GCNp followed by GNp and CNp. The study concluded antibiotic coated ZnO nanoparticles significant candidates modulating antibiotic resistance in MDR E. coli.

Short term therapeutic efficacy of camel milk Vis-À-Vis buffalo milk in Alloxan® induced diabetic rabbits.

PURPOSE: This is the first comparative report that demonstrates the comparison of the anti-hyperglycemic activity of camel milk, buffalo milk and synthetic drugs in induced diabetic rabbits. METHOD: Five groups (n = 8) of rabbits containing placebo (G1) and hyperglycemic groups (Alloxan® administered intravenously) including control diabetic (G2), camel milk treated @40 ml/kg (G3), buffalo milk treated @40 ml/kg (G4) and glibenclamide (Glicon®) @10 mg/kg (G5) orally for 60 days. Collection of blood was done for hematology and biochemical analysis. Renal and hepatic tissue sections were processed by routine paraffin technique for diabetes-induced histopathological changes and anti-diabetic activity of camel and buffalo milk. RESULTS: Diabetes deleteriously (P ≤ 0.05) affects all studied parameters. A significant (P ≤ 0.05) recovery was seen in diabetogenic hematological (RBC, MCV, Hb, MCH) and serological parameters (AST, ALT, creatinine, BUN, TPs, and TOS) with camel milk treatment. Camel milk and glibenclamide decreased blood glucose level more significantly (P < 0.01) than the buffalo milk but more significant renal recovery was seen by renal function. Microscopic observations demonstrated that camel milk and glibenclamide recovered the altered histology of the liver and kidneys towards normal. CONCLUSION: The results indicate that camel milk has a potential therapeutic effect in the treatment of hyperglycemia and plays a significant role in its management as well as reduces the risk of diabetes-related complications as compared to buffalo milk.

Microbial profile of burn wound infections and their antibiotic sensitivity patterns at burn unit of allied hospital Faisalabad.

Microbial infection is the most common and serious complication of burn injury, which is a major cause of morbidity and mortality. The aim of this study was to determine the bacteriological profiles and the antibiotic sensitivity patterns in burn unit of Allied Hospital Faisalabad over a period of 1 year. During the study period, 393 samples were collected and cultured by conventional method. Disk diffusion method was used to determine the sensitivity/resistance pattern of the isolates. Results were analyzed using SPPS version 20. Out of 393, 332 (84.5%) cases were found to be culture positive. Microbial contamination of the burn wounds was significantly (p<0.05) higher in males (89.3%) as compared to females (78.1%), and in 3rd degree burns (92.2%) as compared to 2nd degree burns (80.8%). Out of 393 patients, 258 (65.6%) cases were of Staphylococcus aurous followed by 169 (43.0%) of Pseudomonas aeruginosa 79 (20.1%) of Klebsiella pneumoniae and 67 (17.0%) of Escherichia coli. Among 258 cases of S. aurous, 153 (59.3%) were MRSA and 105 (40.7%) were MSSA. A large proportion (92.8%) of MRSA was sensitive to techoplanin and exhibited high-level resistant (96.7%) to fusidic acid whereas, significant proportion (74.4%) of MSSA isolates showed resistant to fusidic acid. A zero resistance was noted in coagulase negative staphylococci to linezolide, vancomycin and teichoplanin.. Pseudomonas aeruginosa exhibited high level resistance to tobramycin (91.7%) and were mostly sensitive (93.5%) to cefipiem. Klebsiella penumoniae was most sensitive to meropenem (100%) and most resistant to tobramycin (63.3%). E. coli showed zero resistance cefipiem and a small proportion of isolates (14.9%) exhibited resistance to tobramycin. In conclusion, S. aurous and P. aeruginosa represented the most common bacterial microbes of burn wounds which exhibited variable antibiotic susceptibility pattern. This study revealed a high potential for multiple microorganism outbreaks and emergence of resistant pathogens in burn patients due to the lack of patient screening and extended empirical use of antibiotics.